ABEONA THERAPEUTICS INC. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Abeona Therapeutics Inc. on June 11, 2026. The report discloses a corporate governance event involving the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a personnel change and does not contain financial statements or performance data.
Material Changes
On June 11, 2026, Michael Amoroso resigned as a member of the Board of Directors, effective immediately. He also resigned from the Nominating and Corporate Governance Committee. The Company stated that the resignation was not the result of any disagreement regarding operations, policies, or practices, but was solely for personal reasons.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the disclosure of the director's departure.
Key Facts for Investor Verification
- Michael Amoroso has resigned from the Board of Directors and the Nominating and Corporate Governance Committee.
- The resignation is effective as of June 11, 2026.
- The Company attributes the departure to personal reasons with no disagreement on company matters.
- Joseph Vazzano, Chief Financial Officer, signed the report on behalf of the registrant.